BeStock  
Stocks › Biotechnology › EXEL

Exelixis EXEL

US equityMarket cap rank #695Biotechnology
$58.48 +$0.07 (+0.12%)
Market open · Oct 1, 1:10 pm ET · After hours $58.40 -0.02%
Open$58.35
Prev close$58.41
Day range$57.76 – $59.28
Volume562.2K
Market cap$14.49B
P/E (TTM)18.4
Dividend yield–

Analyst view

ConsensusBuy
Analysts6
Average target$53.67-8.2% vs. price
  • Buy 50%
  • Hold 33%
  • Sell 17%
Low $41.00Now $58.48Avg $53.67High $64.00

Recent rating changes

The last 20 actions on file set price targets from $41.00 to $64.00, averaging $51.43.

DateFirmRatingTarget
14 Sep 2026 Truist Financial HOLD –
11 Sep 2026 William Blair BUY –
11 Sep 2026 BofA Securities SELL $41.00
11 Sep 2026 Stifel HOLD –
6 Aug 2026 William Blair BUY –
5 Aug 2026 BofA Securities SELL $41.00
5 Aug 2026 Goldman Sachs BUY $64.00
3 Aug 2026 Truist Financial HOLD –
23 Jul 2026 Goldman Sachs BUY $64.00
7 Jul 2026 Truist Financial HOLD $56.00
2 Jul 2026 H.C. Wainwright BUY $56.00
25 Jun 2026 Truist Financial HOLD $54.00
22 Jun 2026 William Blair BUY –
22 Jun 2026 BofA Securities SELL $41.00
7 May 2026 H.C. Wainwright BUY $56.00
6 May 2026 Morgan Stanley HOLD $50.00
6 May 2026 Stifel HOLD $47.00
6 May 2026 Goldman Sachs BUY $50.00
6 May 2026 Barclays HOLD $45.00
5 May 2026 TD Cowen BUY $55.00

Discussion

No comments yet — be the first to weigh in on EXEL.

Leave a comment

Scroll to Top